Items where Author is "Teh, Lay Kek"

Zakaria, Zainul Amiruddin and Jaios, Ermansyah and Omar, MH and Abdul Rahman, Suzanah and Hamid, SSA and Ching, Siewmooi and Teh, Lay Kek and Salleh, Mohd Zaki and Darnis, Deny Susanti and Bakhtiar, M. Taher (2016) Antinociception of petroleum ether fraction derived from crude methanol extract of Melastoma malabathricum leaves and its possible mechanisms of action in animal models. BMC Complementary and Alternative Medicine, 16 (1). pp. 488-1. ISSN 1472-6882

Zakaria, Zainul Amiruddin and Yahya, Farhana and Mamat, Siti Syariah and Mahmood, Nur Diyana and Mohtaruddin, Norhafizah and Bakhtiar, M. Taher and Abdul Hamid, Siti Selina and Teh, Lay Kek and Salleh, Mohd Zaki (2016) Hepatoprotective action of various partitions of methanol extract of Bauhinia purpurea leaves against paracetamol-induced liver toxicity: involvement of the antioxidant mechanisms. BMC Complementary and Alternative Medicine, 16 (1). pp. 1-16. ISSN 1472-6882

Beshna, E and Teh , Lay Kek and Ngow, Harris Abdullah and Harun, Roslan and Salleh, Mohd Zaki (2010) VKORC1 Haplotypes in patients treated with warfarin. In: National Biotechonology Seminar , 24th-26th May 2010, Putra World Trade Center.

Salleh, Mohd Zaki and Teh , Lay Kek and Immaculate, M. L and Ngow, Harris Abdullah and Harun, Roslan (2009) Lack of correlation between INR and warfarin dose: a role of pharmacogenotyping of CYP2C9*3 and VKORC1 for anticoagulation. In: International Conference on Persomalized Medicine; 5th Joint Conference of Pharmacogenomic ;, 19-20 September 2009, Hong Kong Science Park.

Ngow, Harris Abdullah and Wan Khairina, Wan Mohd Nowalid and Teh , Lay Kek and Lee, Wee Leng and Harun, Roslan and Ismail, Rusli and Salleh, Mohd Zaki (2009) CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia. Singapore Medical Journal, 50 (5). pp. 490-493. ISSN 0037-5675

Ngow, Harris Abdullah and Teh , Lay Kek and Langmia, I. M. and Lew, W. L. and Harun, R. and Ismail, R. and Salleh, Mohd Zaki (2008) Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study. Xenobiotica, 38 (6). pp. 641-651. ISSN 0049-8254